POSEIDA THERAPEUTICS INC

CUSIP: 73730P108 Class: Common Stock

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 3,834,519 Value ($000) $36,811 Avg Close Range
Q3 2024
Shares 3,663,456 Value ($000) $10,477 Avg Close Range
Q2 2024
Shares 3,405,805 Value ($000) $9,945 Avg Close Range
Q1 2024
Shares 3,373,065 Value ($000) $10,760 Avg Close Range
Q4 2023
Shares 2,899,319 Value ($000) $9,742 Avg Close Range
Q3 2023
Shares 2,638,454 Value ($000) $6,280 Avg Close Range
Q2 2023
Shares 2,591,199 Value ($000) $4,561 Avg Close Range
Q1 2023
Shares 2,360,752 Value ($000) $7,271 Avg Close Range
Q4 2022
Shares 2,331,306 Value ($000) $12,356 Avg Close Range
Q3 2022
Shares 2,384,866 Value ($000) $8,419 Avg Close Range
Q2 2022
Shares 1,325,650 Value ($000) $3,420 Avg Close Range
Q1 2022
Shares 1,446,264 Value ($000) $6,479 Avg Close Range
Q4 2021
Shares 1,452,155 Value ($000) $9,889 Avg Close Range
Q3 2021
Shares 1,515,194 Value ($000) $11,046 Avg Close Range
Q2 2021
Shares 1,330,451 Value ($000) $13,331 Avg Close Range
Q1 2021
Shares 1,437,334 Value ($000) $13,727 Avg Close Range
Q4 2020
Shares 588,089 Value ($000) $6,452 Avg Close Range
Q3 2020
Shares 566,951 Value ($000) $5,030 Avg Close Range